The Melanocortin System Explained: From Skin to Appetite to Mood

What Are Melanocortins, Anyway?

If you have ever gotten a tan, felt the urge to eat, experienced a stress response, or noticed changes in your mood, you have the melanocortin system to thank — or blame. It is one of the most ancient and versatile signaling systems in biology, and it touches an astonishing range of bodily functions that most people would never think to connect.

The melanocortin system involves a family of peptide hormones (the melanocortins) and the receptors they activate (MC1R through MC5R). These receptors are scattered across your skin, brain, adrenal glands, immune cells, and more. When researchers talk about peptides that influence pigmentation, appetite, sexual function, inflammation, or energy balance, they are almost always talking about the melanocortin system in one way or another.

This article breaks down the melanocortin system into understandable pieces — what POMC is, how alpha-MSH works, what each of the five receptors does, and which research peptides interact with this system. If you have ever wondered why a single peptide family can influence everything from skin color to body weight, read on.

POMC: The Master Precursor

One Protein, Many Peptides

The story of the melanocortin system starts with a single large protein called proopiomelanocortin — or POMC for short. Think of POMC as a biological Swiss Army knife: it does not do much on its own, but when cellular enzymes cut it apart at specific sites, it produces a remarkable array of smaller active peptides.

These smaller peptides include:

• Alpha-MSH (α-MSH) — the main melanocortin peptide, involved in skin pigmentation, appetite suppression, and anti-inflammatory signaling
• Beta-MSH and gamma-MSH — related melanocortins with overlapping but distinct roles
• ACTH (adrenocorticotropic hormone) — the stress hormone regulator that stimulates cortisol release from the adrenal glands
• Beta-endorphin — the body’s natural opioid peptide, involved in pain modulation and reward

The enzymes that do the cutting — called prohormone convertases (PC1/3 and PC2) — determine which peptides are produced. This is where things get interesting: different tissues produce different convertases, so the same POMC protein gets cut into different peptides depending on where it is being processed.

In the anterior pituitary gland (where PC1/3 is present but PC2 is not), POMC is mainly processed into ACTH. In the hypothalamus and skin (where PC2 is also present), POMC gets further processed into alpha-MSH and the other melanocortins. Same protein, different scissors, different products.

Alpha-MSH: The Star of the Show

A 13-Amino-Acid Peptide With Outsized Influence

Alpha-MSH is a 13-amino-acid neuropeptide that sits at the center of melanocortin biology. It is produced in the skin by melanocytes and keratinocytes (particularly after UV light exposure), in the hypothalamus by POMC neurons, and in immune cells throughout the body. Despite its small size, alpha-MSH has been investigated for roles in:

• Skin pigmentation: Alpha-MSH is the primary signal that tells melanocytes to produce melanin. When UV light hits your skin, keratinocytes ramp up alpha-MSH production, which binds to MC1R on melanocytes and triggers the molecular cascade that produces the eumelanin pigment responsible for tanning. This is fundamentally a DNA-protection mechanism — melanin absorbs UV radiation before it can damage cellular DNA.
• Appetite suppression: In the hypothalamus, alpha-MSH acts as an anorexigenic (appetite-suppressing) peptide. When POMC neurons release alpha-MSH, it binds to MC4R in the brain, sending satiety signals that reduce food intake. This is why MC4R mutations are the most common cause of monogenic (single-gene) obesity in humans.
• Anti-inflammatory activity: Alpha-MSH and its fragments can suppress the production of pro-inflammatory cytokines and downregulate NF-kB — the master transcription factor behind many inflammatory responses. This anti-inflammatory capacity extends to the smallest active fragment of alpha-MSH: the C-terminal tripeptide KPV (Lys-Pro-Val).
• Antimicrobial effects: Research has identified antimicrobial properties in alpha-MSH, adding yet another dimension to this peptide’s biological profile.

The Five Melanocortin Receptors: A Tour

The melanocortin receptors (MC1R through MC5R) are G protein-coupled receptors (GPCRs) — the same type of receptor targeted by a large proportion of modern pharmaceuticals. They share 40-60% sequence homology with each other, which is low enough to give them distinct functions but high enough to explain why many melanocortin ligands interact with multiple receptors (a property called “non-selectivity”).

Here is what each receptor does, where it lives, and why researchers care about it.

MC1R — The Pigmentation Receptor

Location: Primarily melanocytes and immune cells (leukocytes)

Primary function: MC1R is the key regulator of epidermal melanin production. When alpha-MSH binds to MC1R on melanocytes, it activates a signaling cascade (cAMP → PKA → MITF) that upregulates the genes responsible for eumelanin synthesis. This is the molecular mechanism behind tanning.

Beyond pigmentation: MC1R also enhances DNA damage repair mechanisms in melanocytes and has anti-inflammatory signaling functions in immune cells. Loss-of-function MC1R variants are associated with red hair, fair skin, freckling, and increased melanoma risk — not because of increased UV exposure, but because of impaired DNA repair capacity.

Research peptides targeting MC1R: Melanotan I (afamelanotide) is a relatively selective MC1R agonist. Melanotan II is a non-selective agonist that activates MC1R along with other melanocortin receptors. For more detail, see our Melanotan I and Melanotan II research guides.

MC2R — The Stress Response Receptor

Location: Adrenal cortex

Primary function: MC2R is unique among melanocortin receptors because its only natural agonist is ACTH — not the MSH peptides. When ACTH from the pituitary binds to MC2R on adrenal cells, it triggers cortisol production. This is the hypothalamic-pituitary-adrenal (HPA) axis in action, and it is the fundamental mechanism behind the body’s stress response.

Clinical significance: MC2R mutations cause familial glucocorticoid deficiency, a condition where the adrenal glands cannot respond to ACTH. This receptor also requires a specific accessory protein (MRAP) to reach the cell surface, making it structurally unique within the melanocortin family.

Research peptides: MC2R is not typically targeted by research peptides because of its narrow ACTH specificity. However, understanding MC2R function is important for interpreting the broader melanocortin system.

MC3R — The Metabolic and Immune Modulator

Location: Brain (hypothalamus, limbic system), immune cells, gut

Primary function: MC3R has been defined primarily as a regulator of energy homeostasis — the appetite/hunger balance — but research has revealed it as an important modulator of inflammation and cardiovascular function as well. Unlike MC4R (which primarily suppresses appetite), MC3R appears to play a more nuanced role in energy partitioning and nutrient sensing.

Immune function: Stimulation of MC3R (along with MC1R) increases production of the anti-inflammatory cytokine IL-10 from monocytes and macrophages while downregulating inflammatory cytokines like IL-1β and IL-6. In MC3R-knockout mouse studies, animals showed heightened inflammatory responses following ischemia-reperfusion injury, confirming the receptor’s protective role.

Research peptides: Bremelanotide (PT-141) has binding affinity for MC3R as well as MC4R. For details on PT-141 research, see our PT-141 Research Guide.

MC4R — The Appetite and Energy Receptor

Location: Central nervous system (hypothalamus, brainstem, cortex, spinal cord)

Primary function: MC4R is arguably the most clinically significant melanocortin receptor. It sits at the center of the brain’s energy homeostasis circuitry. When alpha-MSH from POMC neurons activates MC4R, it suppresses appetite and increases energy expenditure. When the opposing peptide AgRP (agouti-related protein) blocks MC4R, appetite increases.

Obesity connection: Mutations in MC4R are the most common monogenic cause of obesity, affecting 1-6% of obese patients. More than 150 distinct MC4R mutations have been identified, causing early-onset obesity, hyperphagia (excessive eating), and metabolic abnormalities including hyperinsulinemia. The FDA-approved drug setmelanotide is an MC4R agonist developed specifically for obesity caused by MC4R pathway defects.

Sexual function: MC4R activation in specific brain regions also influences sexual arousal and function. In the hypothalamus, MC4R stimulation triggers nitric oxide release that mediates erectile responses. In the nucleus accumbens and related reward circuits, MC4R activation stimulates dopamine release. This dual role — appetite and sexual function — is why some melanocortin-targeting peptides have effects on both.

Research peptides: Bremelanotide (PT-141) is a melanocortin receptor agonist with preferential activity at MC4R and MC3R, investigated for its effects on sexual function. See our PT-141 Research Guide for more.

MC5R — The Exocrine and Sebaceous Receptor

Location: Brain, skeletal muscle, skin (sebaceous glands), exocrine glands

Primary function: MC5R is the least studied of the five melanocortin receptors, but it has a clear role in exocrine gland function. MC5R-knockout mice show reduced sebaceous gland lipid production, suggesting this receptor regulates sebum output. It may also play roles in fatty acid oxidation in skeletal muscle and thermoregulation.

Research status: MC5R remains relatively underexplored compared to the other melanocortin receptors. Its role in sebaceous gland regulation has attracted interest from dermatological researchers, and its muscle expression suggests potential metabolic functions that have not yet been fully characterized.

How the System Balances Itself: Agonists vs. Antagonists

The melanocortin system does not just have “on” signals. It also has built-in brakes. Two endogenous antagonist proteins — agouti signaling protein (ASIP) and agouti-related protein (AgRP) — compete with alpha-MSH for binding at melanocortin receptors.

• ASIP primarily antagonizes MC1R in the skin, and its overexpression in mice produces the yellow agouti coat color (and obesity, because ASIP also blocks MC4R). In humans, ASIP variants influence skin pigmentation and may modulate melanoma risk.
• AgRP is produced in the hypothalamus and specifically antagonizes MC3R and MC4R. It is the yin to alpha-MSH’s yang in appetite regulation: when you are hungry, AgRP levels rise and block melanocortin-mediated satiety signals. When you are fed, alpha-MSH dominates and suppresses appetite.

This agonist-antagonist balance is what makes the melanocortin system so responsive and finely tuned. It is not a simple on/off switch — it is a continuous tug-of-war between opposing signals, with the balance point determining everything from how dark your skin gets to how much you eat.

Research Peptides That Target the Melanocortin System

Several research peptides interact with melanocortin receptors, each with different selectivity profiles:

Peptide	Primary Targets	Research Focus	Selectivity
Melanotan I (Afamelanotide)	MC1R	Pigmentation, photoprotection	Relatively selective
Melanotan II	MC1R, MC3R, MC4R, MC5R	Pigmentation, appetite, sexual function	Non-selective
PT-141 (Bremelanotide)	MC3R, MC4R	Sexual function research	Preferential MC4R > MC3R
Setmelanotide	MC4R	MC4R pathway obesity	MC4R-selective
KPV (tripeptide)	Non-receptor (PepT1-mediated)	Anti-inflammatory research	Not melanocortin receptor-dependent

Note that Melanotan II’s non-selectivity is both its most interesting research property and its most significant limitation — because it crosses the blood-brain barrier and activates multiple receptor subtypes, it produces effects across pigmentation, appetite, and sexual function simultaneously.

The Melanocortin System and Inflammation

One of the most active areas of melanocortin research involves the system’s anti-inflammatory properties. Alpha-MSH and its fragments suppress NF-kB activation — the transcription factor that drives the expression of most inflammatory genes. This effect has been documented across multiple melanocortin receptor subtypes:

• MC1R on immune cells mediates anti-inflammatory signaling when activated by alpha-MSH
• MC3R on macrophages and monocytes promotes IL-10 production (anti-inflammatory) while suppressing IL-1β and IL-6 (pro-inflammatory)
• KPV (the C-terminal tripeptide of alpha-MSH) achieves anti-inflammatory effects through a completely different mechanism — it is transported into cells by the peptide transporter PepT1, where it directly inhibits NF-kB and MAPK inflammatory signaling pathways without needing to bind a melanocortin receptor at all

This anti-inflammatory dimension has driven research into melanocortin peptides for inflammatory bowel disease, arthritis, multiple sclerosis, sarcoidosis, and other inflammatory conditions.

Melanocortins and the Brain: Mood, Motivation, and Behavior

The melanocortin system’s presence throughout the central nervous system means it influences more than appetite and sexual function. Alpha-MSH and its receptors have been investigated for roles in:

• Stress response: Beyond ACTH’s direct role in cortisol production via MC2R, melanocortin signaling in the brain modulates anxiety-like behavior and stress reactivity
• Motivation and reward: MC4R is expressed in dopaminergic reward circuits, and its activation influences motivated behavior and reinforcement learning
• Neuroprotection: Alpha-MSH has demonstrated neuroprotective effects in various models of neural injury, potentially mediated through anti-inflammatory and anti-apoptotic mechanisms
• Thermoregulation: Central melanocortin signaling participates in the regulation of body temperature, linking energy balance to thermal homeostasis

The breadth of melanocortin involvement in brain function helps explain why non-selective melanocortin agonists like Melanotan II produce such a wide range of central effects — they are activating receptors across multiple brain regions simultaneously.

Why This System Matters for Peptide Research

Understanding the melanocortin system is essential for anyone working with peptides that interact with MC receptors. Here is why:

1. Selectivity predicts side effects. The more receptors a peptide activates, the broader its effects — and the more potential for unintended actions. Melanotan I’s relative selectivity for MC1R means fewer central effects. Melanotan II’s broad activity means effects on pigmentation, appetite, and sexual function all at once.
2. The system is interconnected. You cannot fully isolate pigmentation from appetite from inflammation when working within the melanocortin system. Research designs should account for effects across multiple endpoints.
3. Endogenous antagonists matter. AgRP and ASIP are not just academic curiosities — they actively modulate the responses to exogenous melanocortin peptides, and their expression levels can vary between subjects.
4. Clinical translation is advancing. Setmelanotide’s approval for MC4R-pathway obesity and bremelanotide’s approval for HSDD demonstrate that the melanocortin system is clinically targetable. More selective compounds are in development.

Explore related research guides: Melanotan I | Melanotan II | PT-141 (Bremelanotide)

Summary of Key Research References

Study	Year	Type	Focus	Reference
Cai & Bhatt	2023	Review	MC1R pharmacology and therapeutic aspects	PMC10418475
Xu et al.	2018	Review	Melanocortin receptor system in degenerative diseases	PMC5999398
Dores et al.	2024	Review	Intracellular signaling mechanisms of melanocortin receptors	PMC11113477
Tao	2010	Review	MC4R physiology, pharmacology, and pathophysiology	PMC3365848
Dores & Baron	2022	Review	MC4R complexity in energy homeostasis and obesity	PMC9302617
Cawley et al.	2016	Review	POMC biosynthesis, trafficking, and secretion	PMC4899099
Toda et al.	2018	Review	POMC: physiological power of hormone processing	PMC6170974
Moscowitz & Bhatt	2023	Review	Alpha-MSH biology and clinical relevance in melanoma	PMC10463388
Catania	2014	Review	Alpha-MSH as anti-inflammatory antimicrobial peptide	PMC4130143
Kingsbury et al.	2019	Clinical (Phase 3)	Bremelanotide for hypoactive sexual desire disorder	PMC6819021
Getting et al.	2009	In vivo	MC3R-null mice and inflammatory phenotype	PMC2700033
Drzymala et al.	2023	Review	Specific functions of MC3R	PMC9976164

Written by NorthPeptide Research Team

---

Research Disclaimer

For laboratory and research use only. Not for human consumption.

This article is intended solely as a summary of published scientific research. It does not constitute medical advice, treatment recommendations, or an endorsement for any therapeutic purpose. The research discussed herein is predominantly preclinical, and results may not translate to human outcomes. Researchers should consult relevant institutional review boards and regulatory guidelines before designing studies involving these compounds.

NorthPeptide supplies research-grade peptides for legitimate scientific investigation. All products are sold strictly for laboratory and research purposes.